These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 32924144)

  • 1. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
    Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
    JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.
    Salazar de Pablo G; Catalan A; Vaquerizo Serrano J; Pedruzo B; Alameda L; Sandroni V; Armendariz A; Rodriguez V; Arango C; Moreno C; Downs J; Abbott C; Shin JI; Solmi M; Fusar-Poli P; Correll CU
    Br J Psychiatry; 2023 Jul; 223(1):282-294. PubMed ID: 37194556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.
    Solmi M; Soardo L; Kaur S; Azis M; Cabras A; Censori M; Fausti L; Besana F; Salazar de Pablo G; Fusar-Poli P
    Mol Psychiatry; 2023 Jun; 28(6):2291-2300. PubMed ID: 37296309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.
    Fusar-Poli P; Spencer T; De Micheli A; Curzi V; Nandha S; McGuire P
    Eur Neuropsychopharmacol; 2020 Oct; 39():111-122. PubMed ID: 32921544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis.
    De Micheli A; Provenzani U; Solmi M; Van Pabst AVL; Youssef E; McGuire P; Fusar-Poli P
    Schizophr Res; 2023 Apr; 254():109-115. PubMed ID: 36827942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analyzing the prevalence and prognostic effect of antipsychotic exposure in clinical high-risk (CHR): when things are not what they seem.
    Raballo A; Poletti M; Preti A
    Psychol Med; 2020 Dec; 50(16):2673-2681. PubMed ID: 33198845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.
    Oliver D; Arribas M; Radua J; Salazar de Pablo G; De Micheli A; Spada G; Mensi MM; Kotlicka-Antczak M; Borgatti R; Solmi M; Shin JI; Woods SW; Addington J; McGuire P; Fusar-Poli P
    Mol Psychiatry; 2022 Sep; 27(9):3670-3678. PubMed ID: 35665763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a clinical service to prevent psychosis: What, how and when? Systematic review.
    Salazar de Pablo G; Estradé A; Cutroni M; Andlauer O; Fusar-Poli P
    Transl Psychiatry; 2021 Jan; 11(1):43. PubMed ID: 33441556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis.
    Salazar de Pablo G; Davies C; de Diego H; Solmi M; Shin JI; Carvalho AF; Radua J; Fusar-Poli P
    Eur Psychiatry; 2021 Jul; 64(1):e51. PubMed ID: 34315555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
    Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
    Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial Perspective: Psychosis risk in adolescence - outcomes, comorbidity, and antipsychotics.
    Raballo A; Poletti M; Preti A
    J Child Psychol Psychiatry; 2022 Feb; 63(2):241-244. PubMed ID: 34085715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.
    Salazar de Pablo G; Radua J; Pereira J; Bonoldi I; Arienti V; Besana F; Soardo L; Cabras A; Fortea L; Catalan A; Vaquerizo-Serrano J; Coronelli F; Kaur S; Da Silva J; Shin JI; Solmi M; Brondino N; Politi P; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2021 Sep; 78(9):970-978. PubMed ID: 34259821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.
    Mensi MM; Molteni S; Iorio M; Filosi E; Ballante E; Balottin U; Fusar-Poli P; Borgatti R
    Schizophr Bull; 2021 Oct; 47(6):1663-1673. PubMed ID: 33939829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences.
    Raballo A; Poletti M; Preti A; McGorry P
    Schizophr Res; 2022 May; 243():254-261. PubMed ID: 32307261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.